MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Unspecified adverse effect of drug or medicament (T88.7)

HealthDay 10 July at 03.12 PM

Most Children With Conjunctivitis Have Rx for Topical Antibiotics Filled

More than two-thirds of children with conjunctivitis have a prescription filled for topical antibiotics within one day of an ambulatory care visit, according to a research letter published online June 27 in JAMA Ophthalmology.Daniel J. Shapiro, M.D., M.P.H., from the University of California, San Francisco, and colleagues examined pr

HealthDay 09 July at 03.51 PM

Acupuncture May Relieve Pain-Specific Disability in Degenerative Lumbar Stenosis

For patients with degenerative lumbar spinal stenosis (DLSS) and predominantly neurogenic claudication pain symptoms, acupuncture may relieve pain-specific disability, according to a study published online July 2 in the Annals of Internal Medicine.Lili Zhu, M.D., from the China Academy of Chinese Medical Sciences in Beijing, and colleag

HealthDay 09 July at 03.32 PM

1999 to Mid-2000s Saw Increase in Seniors Using Prescription Meds

From 1999 to the mid-2000s, the proportion of U.S. adults aged 65 years or older who used prescription medications increased, according to a research letter published online July 1 in JAMA Internal Medicine.Gabriel K. Innes, V.M.D., Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues analyzed dat

HealthDay 01 July at 03.22 PM

Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer

For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line treatment, according to a study published online June 26 in the New England Journal of Medicine.Byoung C. Cho, M.D., Ph.D., from the Yonsei Cancer Ce

HealthDay 26 June at 03.26 PM

ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure

For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar improvements in heart failure-related symptoms in men and women, according to a study published online June 23 in the Journal of the American College of Cardiology to coinc